Back to results
US 2026/0049159 A1Published application
Antibody-alk5 inhibitor conjugates and their uses
AssigneeSynthis Therapeutics, Inc.
InventorDori A. Thomas-Karyat
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to antibody-drug conjugates comprising ALK5 inhibitors and their uses.
Claims21
An antibody-ALK5 inhibitor conjugate (ADC) comprising an ALK5 inhibitor operably linked to an antibody or antigen binding fragment that binds to a T cell surface molecule.
Dependencies are inferred from the claim text.